Results 131 to 140 of about 102,578 (164)
Some of the next articles are maybe not open access.

GFAP IgG associated inflammatory polyneuropathy

Journal of Neuroimmunology, 2020
GFAP (glial fibrillary acidic protein)-IgG is predominantly associated with meningoencephalomyelitis, and neuropathy presentations are rare.We reviewed clinical, electrodiagnostic and histopathological presentations of GFAP-IgG associated peripheral neuropathy.We identified six cases, five of whom had peripheral neuropathy as the initial presentation ...
Pritikanta, Paul   +7 more
openaire   +2 more sources

NMOSD or GFAP astrocytopathy? A case report

Multiple Sclerosis and Related Disorders, 2020
We describe a 43-year-old female whose manifestations fulfilled the diagnostic criteria of aquaporin-4 IgG negative neuromyelitis optica spectrum disorders (NMOSD). High titer of glial fibrillary acidic protein (GFAP) antibody was detected in cerebrospinal fluid. In this case, some symptoms pertained to NMOSD and some to GFAP antibody-related disorders.
Yue Zhang   +2 more
openaire   +2 more sources

The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases

open access: yesJournal of Neurochemistry
Glial fibrillary acidic protein (GFAP) is a well-established biomarker of reactive astrogliosis in the central nervous system because of its elevated levels following brain injury and various neurological disorders. The advent of ultra-sensitive methods for measuring low-abundant proteins has significantly enhanced our understanding of GFAP levels in ...
Elly Hol, Lisa Vermunt, S Abeln
exaly   +2 more sources

Anaplasia and Heterogeneity of Gfap Expression in Gliomas

Tumori Journal, 1986
GFAP (glial fibrillary acidic protein) distribution was investigated in selected areas of glioblastomas and astrocytomas. The proliferating cell population of glioblastomas was GFAP negative and contained many mitoses which were also negative. The old, deeply located areas were composed of cells with visible cytoplasm, intensely GFAP-positive; mitoses ...
D, Schiffer   +3 more
openaire   +2 more sources

Clinical characteristics of autoimmune GFAP astrocytopathy

Journal of Neuroimmunology, 2019
The clinical features of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy remain to be elucidated. We describe here the clinical features of 14 patients with GFAP astrocytopathy confirmed by detection of GFAP-IgG in cerebrospinal fluid (CSF). The novel findings of this study are as follows.
Akio, Kimura   +4 more
openaire   +2 more sources

Measurement of glial fibrillary acidic protein (GFAP) and anti-GFAP antibodies by solid-phase radioimmunoassays

Acta Neurologica Scandinavica, 2009
A solid-phase radioimmunoassay was developed for the detection of glial fibrillary acidic protein (GFAP) and GFAP-specific immunoglobulin G (IgG) antibodies. In antibody assays purified GFAP was absorbed onto polystyrene beads, followed by incubation in dilutions of serum.
J, Ruutiainen   +4 more
openaire   +2 more sources

Proliferative assessment of GFAP-positive and GFAP-negative glioma cells by nucleolar organizer region staining

Surgical Neurology, 1991
The proliferative potential of two types of tumor cells that did or did not express glial fibrillary acidic protein (GFAP) in 19 cases of high-grade gliomas, including nine anaplastic astrocytomas (WHO criteria, grade 3) and 10 glioblastoma multiforme (grade 4), was investigated by a combined staining technique, one-step silver colloid method for ...
A, Hara   +6 more
openaire   +2 more sources

INCREASES IN GFAP AND GFAP mRNA IN BRINDLED MOUSE CNS.

Journal of Neuropathology and Experimental Neurology, 1987
B. Shafit-Zagardo   +2 more
openaire   +1 more source

GFAP

1998
Tak W. Mak   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy